Literature DB >> 19727817

Gene expression profiles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum.

Yunhong Xia1, Rongxin Chen, Zhenji Song, Shenglong Ye, Ruixia Sun, Qiong Xue, Zhe Zhang.   

Abstract

PURPOSE: Hepatic stellate cells (HSCs) transdifferentiate to become extracellular matrix-producing myofibroblasts during liver injury. Myofibroblasts can also promote invasion and metastasis of hepatocellular carcinoma (HCC). In this study, we determined gene expression changes in two different models of HSC activation, induction-activated HSCs (iHSCs) and culture-activated HSCs (cHSCs).
METHODS: Hepatic stellate cells were isolated by density centrifugation and exposed to conditioned medium (CM) from the rat HCC cell line C5F, and fetal bovine serum (FBS). Expression of 27,100 genes in quiescent HSCs, cHSCs and iHSCs was analyzed by microarray and was confirmed on a subset of genes by real-time RT-PCR and Western blot.
RESULTS: One thousand nine hundred sixty-seven genes were differentially expressed in cHSCs and iHSCs, including genes that encode proinflammatory factors, adhesion molecules, cell surface receptors, signaling transduction and immune factors such as Il1a, Vcam1, Ccl6, Ilr7, PRAP, osteopontin, Gp39, Raf1, Rac2, Adam17, Wnt6, MMP-9, and Cfd. C5F-CM-induced activation only partially reproduced the gene expression changes observed during FBS culture activation. iHSCs showed specific gene expression, suggesting that HCC cells can specifically induce HSC activation.
CONCLUSIONS: Induction- activated HSCs' gene expression patterns were partially similar to and different from that of cHSCs. iHSCs might play an important role in invasion and metastasis of HCC. This study provided theoretical foundations for investigating the biology of HSCs in HCC.

Entities:  

Mesh:

Year:  2010        PMID: 19727817     DOI: 10.1007/s00432-009-0666-5

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

1.  Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells.

Authors:  Sahyun Hong; Kwan-Kyu Park; Junji Magae; Kunio Ando; Tae-Sung Lee; Taeg Kyu Kwon; Jong-Young Kwak; Cheorl-Ho Kim; Young-Chae Chang
Journal:  J Biol Chem       Date:  2005-04-29       Impact factor: 5.157

2.  Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.

Authors:  V Neaud; S Faouzi; J Guirouilh; B Le Bail; C Balabaud; P Bioulac-Sage; J Rosenbaum
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

Review 3.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

4.  Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.

Authors:  Patrick A Adegboyega; Omiyosoye Ololade; Jamal Saada; Randy Mifflin; John F Di Mari; Don W Powell
Journal:  Clin Cancer Res       Date:  2004-09-01       Impact factor: 12.531

5.  Gene expression profiles during hepatic stellate cell activation in culture and in vivo.

Authors:  Samuele De Minicis; Ekihiro Seki; Hiroshi Uchinami; Johannes Kluwe; Yonghui Zhang; David A Brenner; Robert F Schwabe
Journal:  Gastroenterology       Date:  2007-02-21       Impact factor: 22.682

6.  Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas.

Authors:  T Terada; K Makimoto; N Terayama; Y Suzuki; Y Nakanuma
Journal:  J Hepatol       Date:  1996-06       Impact factor: 25.083

7.  Portal and parenchymal alterations of the liver in idiopathic portal hypertension: a histological and immunochemical study.

Authors:  Koichi Tsuneyama; Wataru Kouda; Yasuni Nakanuma
Journal:  Pathol Res Pract       Date:  2002       Impact factor: 3.250

8.  Myofibroblasts and hepatocellular carcinoma: an in vivo and in vitro study.

Authors:  J T Nhieu; I Brochériou; A M Préaux; A Mallat; D Cherqui; E S Zafrani; P Mavier
Journal:  J Hepatol       Date:  1998-07       Impact factor: 25.083

9.  Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta ) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent.

Authors:  Chenghai Liu; Marianna D A Gaça; E Scott Swenson; Vincent F Vellucci; Michael Reiss; Rebecca G Wells
Journal:  J Biol Chem       Date:  2003-01-22       Impact factor: 5.157

10.  Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma.

Authors:  Mitsuru Futakuchi; Kumiko Ogawa; Masashi Sano; Seiko Tamano; Fumitaka Takeshita; Tomoyuki Shirai
Journal:  Jpn J Cancer Res       Date:  2002-10
View more
  15 in total

1.  Analysis of gene expression profiles of liver stellate cells during liver regeneration in rats.

Authors:  Cunshuan Xu; Xiaoguang Chen; Cuifang Chang; Gaiping Wang; Wenbo Wang; Lianxing Zhang; Qiushi Zhu; Lei Wang; Fuchun Zhang
Journal:  Mol Cells       Date:  2010-11-26       Impact factor: 5.034

2.  Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma.

Authors:  Cédric Coulouarn; Anne Corlu; Denise Glaise; Isabelle Guénon; Snorri S Thorgeirsson; Bruno Clément
Journal:  Cancer Res       Date:  2012-03-14       Impact factor: 12.701

3.  Rosuvastatin counteracts vessel arterialisation and sinusoid capillarisation, reduces tumour growth, and prolongs survival in murine hepatocellular carcinoma.

Authors:  Annemilaï Tijeras-Raballand; Patricia Hainaud-Hakim; Jean-Olivier Contreres; Caroline Gest; Carole Le Henaff; Bernard I Levy; Marc Pocard; Claudine Soria; Evelyne Dupuy
Journal:  Gastroenterol Res Pract       Date:  2011-02-22       Impact factor: 2.260

4.  Replacement of retinyl esters by polyunsaturated triacylglycerol species in lipid droplets of hepatic stellate cells during activation.

Authors:  Nicole Testerink; Mokrish Ajat; Martin Houweling; Jos F Brouwers; Vishnu V Pully; Henk-Jan van Manen; Cees Otto; J Bernd Helms; Arie B Vaandrager
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

5.  Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma.

Authors:  Lingyin Zhu; Lin Ren; Yingxuan Chen; Jingyuan Fang; Zhizheng Ge; Xiaobo Li
Journal:  J Cell Mol Med       Date:  2015-06-23       Impact factor: 5.310

6.  Prophylactic role of coenzyme Q10 and Cynara scolymus L on doxorubicin-induced toxicity in rats: Biochemical and immunohistochemical study.

Authors:  Hesham N Mustafa; Sally A El Awdan; Gehan A Hegazy; Gehad A Abdel Jaleel
Journal:  Indian J Pharmacol       Date:  2015 Nov-Dec       Impact factor: 1.200

7.  The fibrotic microenvironment as a heterogeneity facet of hepatocellular carcinoma.

Authors:  Krista Rombouts; Vinicio Carloni
Journal:  Fibrogenesis Tissue Repair       Date:  2013-09-16

8.  Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.

Authors:  Rui Liao; Han Wu; Yong Yi; Jia-Xing Wang; Xiao-Yan Cai; Hong-Wei He; Yun-Feng Cheng; Jian Zhou; Jia Fan; Jian Sun; Shuang-Jian Qiu
Journal:  J Exp Clin Cancer Res       Date:  2013-04-19

9.  Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice.

Authors:  Itai Spector; Yael Zilberstein; Adi Lavy; Arnon Nagler; Olga Genin; Mark Pines
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Employment of gene expression profiling to identify transcriptional regulators of hepatic stellate cells.

Authors:  Hideaki Shimada; Lakshman E Rajagopalan
Journal:  Fibrogenesis Tissue Repair       Date:  2012-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.